New Website Highlights Diaceutics Leadership in Personalized Medicine-Focused Consulting and Software Applications

Enhanced Interactive Content, Videos and Blog Showcase Diaceutics Expertise in Personalized Medicine

BELFAST, UNITED KINGDOM--(Marketwire - Jul 23, 2012) - Diaceutics today announced the re-launch of the company's website ( with numerous new features and resources. Diaceutics improved website is a go-to resource for news and information about how pharmaceutical and diagnostic companies can improve their workflows to develop and successfully commercialize personalized medicine (PM) products.

Visitors to the website will find new features and a streamlined layout including:

  • An Online PM Readiness Assessment to help companies gauge whether their teams have the requisite skills and knowledge to develop a PM asset;

  • Information about the DxExcellence Primer, a web-based educational and training resource to help companies accelerate PM success;

  • New Client Success Stories highlighting how Diaceutics has helped pharmaceutical and diagnostic companies overcome planning and other challenges to develop and commercialize profitable PM products;

  • An interactive Diaceutics Blog that will discuss the latest developments in PM and how they affect PM companies and stakeholders;

  • A Leadership e-Brief review of Diaceutics landmark "Pharma Readiness for PM" report informed by interviews with PM leaders at Amgen, Pfizer, Bristol-Myers Squibb, Sanofi and others; and

  • Information about Diaceutics Fusion, a proprietary, web-based, software application that provides a range of business intelligence and performance management applications used for PM planning, collaboration and decision-making.

"We envision the new website as a go-to hub for pharmaceutical and diagnostic companies seeking information, services and resources about how to more effectively develop new targeted therapies and diagnostic tools," said Peter Keeling, Chief Executive Officer of Diaceutics. "Our hands-on PM experience on over 25 assets has taught us the best practices in PM product development and how to manage successful PM collaborations and partnerships."

Also launched today was a new website for Labceutics, the newest division of Diaceutics, ( Labceutics partners with leading laboratories in the EU and Asia to provide pharmaceutical and diagnostic companies with a "one-stop" PM laboratory partner.

Utilizing its proprietary web platform Labceutics CONNECT™, all of the labs, other stakeholders and KOL members of the Labceutics network have the ability to easily and effectively discuss all aspects of the diagnostic environment and provide clients with the visibility and key metrics they require for a successful diagnostic implementation. Like its parent company, Labceutics new website contains client success stories and information about how its services can benefit pharmaceutical and diagnostic companies in the PM space. 

About Diaceutics 
Diaceutics is the leading provider of personalized medicine consulting, software and service solutions for the pharmaceutical and diagnostic industries. We standardize the planning, analytical and action steps needed for the successful development, commercialization and launch of targeted therapies with a proven process for cost-effective, repeatable results that unlock the financial promise of personalized medicine. Learn more at

Contact Information:

Mollie Roth
Chief Operating Officer
(202) 280-5887